²é¿´: 1389  |  »Ø¸´: 14
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

lovelhw

½ð³æ (³õÈëÎÄ̳)

[ÇóÖú] ¹òÇó°ïÎÒ·­ÒëÒ»ÏÂÕâ¶ÎÎÄ×Ö£¬Ö°³ÆÂÛÎļ±ÐèÒª

Ä¿µÄ  ¹Û²ì°¢Íз¥ËûÍ¡ÁªºÏ°¢Ë¹Æ¥ÁÖÖÎÁÆÔ­·¢ÐÔ¸ßѪѹºÏ²¢¾±¶¯ÂöÖàÑùÓ²»¯°ß¿éµÄÁÆÐ§¡£·½·¨  ´æÔÚ¾±¶¯ÂöÖàÑùÓ²»¯°ß¿éµÄÔ­·¢ÐÔ¸ßѪѹ»¼Õß60Àý£¬Ëæ»ú·ÖΪ¶ÔÕÕ×é×é30Àý£¬¸øÓèµ¥Óð¢Ë¹Æ¥ÁÖÆ¬£¬ÖÎÁÆ×é30Àý£¬¸øÓè°¢Íз¥ËûÍ¡ÁªºÏ°¢Ë¹Æ¥ÁÖ£»ÖÎÁÆÇ°¼°ÖÎÁƺó1¡¢3¡¢6Ô²ⶨ»¼ÕßÈýõ£¸ÊÓÍ(TG)¡¢ÑªÇå×ܵ¨¹Ì´¼(CH)¡¢µÍÃܶÈÖ¬µ°°×µ¨¹Ì´¼(LDL¡ªC)¡¢ÈéËáÍÑÇâø(LDH)ºÍ¾±¶¯ÂöÄÚÖÐĤºñ¶È(IMT)¡¢°ß¿é»ý·ÖµÄ±ä»¯¡£½á¹û ÖÎÁÆ6¸öÔºóÈýõ£¸ÊÓÍ(TG)¡¢×ܵ¨¹Ì´¼(TC)¡¢ÑªÇå×ܵ¨¹Ì´¼(CH)¡¢µÍÃܶÈÖ¬µ°°×µ¨¹Ì´¼(LDL¡ªC)¡¢°ß¿é»ý·ÖºÍ¾±¶¯ÂöÄÚÖÐĤºñ¶È(IMT)¡¢·Ö±ðΪ(2.05ÍÁ0.9)mmol£¯L  ½áÂÛ °¢Íз¥ËûÍ¡ÁªºÏ°¢Ë¹Æ¥ÁÖ£¬¶ÔËõС¾±¶¯ÂöÖàÑù°ß¿éÌå»ý¡¢Îȶ¨°ß¿é¡¢½µµÍѪ֬¸÷ÏîÖ¸±êÓнϺõÄЧ¹û£¬¿É×÷Ϊԭ·¢ÐÔ¸ßѪѹºÏ²¢¾±¶¯ÂöÖàÑùÓ²»¯°ß¿éÖÎÁƵÄÁªºÏÒ©Îï¡£
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

befair

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ...
°®ÓëÓêÏÂ: ½ð±Ò+1 2013-11-16 06:03:08
lovelhw(phu_grassman´ú·¢): ½ð±Ò+50, you're always so kind 2014-01-16 15:55:52
lovelhw(phu_grassman´ú·¢): ½ð±Ò+25, thanks 2014-01-16 15:56:02
Objectives: To observe effectiveness of using atorvastatin in combination with aspirin for primary hypertension complicated by carotid atherosclerotic lesions.
Methodology: The 60 patients of primary hypertension with carotid atherosclerotic lesions are randomly put into a control group of 30 patients who are prescribed  aspirin only, and a treatment group of 30 patients who are prescribed atorvastatin and aspirin. Prior to the treatment and one, three and six months after it,  the patients are tested for their TG, CH, LDL-C, LDH, IMT and crouse score, in particular the changes.
Results: Six months after the treatment, all the TG, TC, CH, LDL-C, IMT values are (2.05ÍÁ0.9)mmol£¯L
Conclusions: Atorvastatin in combination with aspirin is effective for reducing volume of carotid atherosclerotic lesions, stabalising the crouse and reducing blood fat as well as other indices. Hence it can be used as a drug combination for treatment of  primary hypertension with carotid atherosclerotic lesions.
½á¹ûÒ»¾ä£º Ô­ÎÄ˵ÄÇЩָ±ê¶¼·Ö±ðÊÇ (2.05ÍÁ0.9)mmol£¯L£¬ ÄÇô¾ÍÊÇ˵ËüÃǶ¼ÊÇ (2.05ÍÁ0.9)mmol£¯L£¿»¹ÊÇËüÃÇ·Ö±ðÊÇA£¬ B£¬ C,¡£¡£¡£ÇëÈ·ÈÏ
·Ç±¾×¨Òµ£¬½ö¹©²Î¿¼
Befairorbeaware
4Â¥2013-10-26 16:22:37
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 15 ¸ö»Ø´ð

befair

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

ÄãºÃ£¬¿´Äã±È½Ï׿±£¬µ«ÒòΪ²»ÊÇÕâ¸öרҵµÄ£¬ÕâÀïµÄרҵ´Ê»ãÌ«¶à£¬·­ÆðÀ´ÄÑÒÔרҵ¡£Èç¹ûÄ㻹ÐèÒª°ïÖúµÄ»°£¬¿É·ñÏȸø³öרҵ´Ê»ã£¬´ó¼Ò¿ÉÒÔ°ïÖúÄã×éÖ¯Æð½á¹¹À´£¿
Befairorbeaware
2Â¥2013-10-25 20:19:03
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lovelhw

½ð³æ (³õÈëÎÄ̳)

°¢Íз¥ËûÍ¡Atorvastatin         °¢Ë¹Æ¥ÁÖAspirin         Ô­·¢ÐÔ¸ßѪѹprimary hypertension
¾±¶¯ÂöÖàÑùÓ²»¯°ß¿éCarotid atherosclerotic lesions            Èýõ£¸ÊÓÍtriglyceride   
ѪÇå×ܵ¨¹Ì´¼cholesteol    µÍÃܶÈÖ¬µ°°×µ¨¹Ì´¼low density lipoprotein-cholesterol
ÈéËáÍÑÇâølactate dehydrogenase            ¾±¶¯ÂöÄÚÖÐĤºñ¶ÈIntima-media thickness
°ß¿é»ý·Öcrouse score        ÑªÖ¬blood fat         ¸Ð¼¤¸÷λ´óÏÀ£¡£¡£¡
3Â¥2013-10-26 10:19:32
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lovelhw

½ð³æ (³õÈëÎÄ̳)

ÊÇA£¬ B£¬ C,¡£¡£¡£
5Â¥2013-10-26 20:37:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Áº³ÉΰÀÏʦ¿ÎÌâ×é»¶Ó­ÄãµÄ¼ÓÈë +9 һѼѼӴ 2026-03-14 11/550 2026-03-19 17:22 by £¡±¾°µÒ»´Î£¡
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +4 z1z2z3879 2026-03-14 6/300 2026-03-19 17:18 by fei626-918
[¿¼ÑÐ] ¡¾¿¼Ñе÷¼Á¡¿»¯Ñ§×¨Òµ 281·Ö£¬Ò»Ö¾Ô¸ËÄ´¨´óѧ£¬³ÏÐÄÇóµ÷¼Á +5 ³Ô³Ô³Ô²ÅÓÐÒâÒå 2026-03-19 5/250 2026-03-19 16:18 by 30660438
[¿¼ÑÐ] Ò»Ö¾Ô¸Î人Àí¹¤²ÄÁϹ¤³Ìר˶µ÷¼Á +4 Doleres 2026-03-19 4/200 2026-03-19 15:27 by ¶¡¶¡*
[¿¼ÑÐ] 085601²ÄÁϹ¤³Ìר˶Çóµ÷¼Á +10 Ľº®mio 2026-03-16 10/500 2026-03-19 15:26 by ¶¡¶¡*
[¿¼ÑÐ] 266Çóµ÷¼Á +5 ÑôÑôÍÛÈû 2026-03-14 10/500 2026-03-19 15:08 by ÑôÑôÍÛÈû
[¿¼ÑÐ] Ò»Ö¾Ô¸Öк£Ñó²ÄÁϹ¤³Ìר˶330·ÖÇóµ÷¼Á +7 С²Ä»¯±¾¿Æ 2026-03-18 7/350 2026-03-19 10:46 by Linda Hu
[¿¼ÑÐ] 298-Ò»Ö¾Ô¸Öйúũҵ´óѧ-Çóµ÷¼Á +7 ÊÖ»úÓû§ 2026-03-17 7/350 2026-03-18 14:34 by vgtyfty
[¿¼ÑÐ] 303Çóµ÷¼Á +4 î£08 2026-03-17 6/300 2026-03-18 11:01 by Iveryant
[¿¼ÑÐ] ÉúÎïѧ071000 329·ÖÇóµ÷¼Á +3 ÎÒ°®ÉúÎïÉúÎﰮΠ2026-03-17 3/150 2026-03-18 10:12 by macy2011
[¿¼ÑÐ] 265Çóµ÷¼Á +3 ÁºÁºÐ£Ð£ 2026-03-17 3/150 2026-03-18 09:12 by zhukairuo
[¿¼ÑÐ] 301Çóµ÷¼Á +9 yyÒªÉϰ¶Ñ½ 2026-03-17 9/450 2026-03-18 08:58 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 296Çóµ÷¼Á +5 ´ó¿Ú³Ô·¹ ÉíÌ彡 2026-03-13 5/250 2026-03-17 21:05 by ²»»ó¿ÉÀÖ
[¿¼ÑÐ] ²ÄÁÏר˶326Çóµ÷¼Á +6 Ä«ìÏæ¦Ý· 2026-03-15 7/350 2026-03-17 17:10 by ruiyingmiao
[¿¼ÑÐ] ¿¼Ñе÷¼Á +3 ä¿ya_~ 2026-03-17 5/250 2026-03-17 09:25 by Winj1e
[¿¼ÑÐ] 0854¿ØÖƹ¤³Ì 359Çóµ÷¼Á ¿É¿çרҵ +3 626776879 2026-03-14 9/450 2026-03-16 17:42 by 626776879
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐʦ·¶071000£¬325Çóµ÷¼Á +6 RuitingC 2026-03-12 6/300 2026-03-16 14:50 by ¿Éµ­²»¿ÉÍü
[¿¼ÑÐ] Öпƴó²ÄÁÏÓ뻯¹¤319Çóµ÷¼Á +3 ÃÏöβÄÁÏ 2026-03-14 3/150 2026-03-14 20:10 by ms629
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +3 ºôºô£¿~+123456 2026-03-14 3/150 2026-03-14 16:53 by WTUChen
[¿¼ÑÐ] 266Çóµ÷¼Á +4 ѧԱ97LZgn 2026-03-13 4/200 2026-03-14 08:37 by zhukairuo
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û